{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:48:55Z","timestamp":1792514935843,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejpb.2021.05.025","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T20:10:21Z","timestamp":1622319021000},"page":"337-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Screening of metabolites in the treatment of liver cancer xenografts HepG2\/ADR by psoralen-loaded lipid nanoparticles"],"prefix":"10.1016","volume":"165","author":[{"given":"Lihong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengteng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Mezhuev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristidis Michael","family":"Tsatsakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra Buha","family":"\u0110or\u0111evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejpb.2021.05.025_b0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u2018Metabonomics\u2019: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejpb.2021.05.025_b0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pnmrs.2014.09.001","article-title":"NMR-based metabolomics: From sample preparation to applications in nutrition research","volume":"83","author":"Brennan","year":"2014","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"issue":"11","key":"10.1016\/j.ejpb.2021.05.025_b0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jnutbio.2011.05.016","article-title":"Analytical metabolomics: nutritional opportunities for personalized health","volume":"22","author":"Elizabeth","year":"2011","journal-title":"J. Nutr. Biochem."},{"issue":"21","key":"10.1016\/j.ejpb.2021.05.025_b0020","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-10-1319","article-title":"Early Detection of Recurrent Breast Cancer Using Metabolite Profiling","volume":"70","author":"Asiago","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ejpb.2021.05.025_b0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ajcn\/82.3.497","article-title":"Metabolomics in human nutrition: opportunities and challenges","volume":"82","author":"Gibney","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.ejpb.2021.05.025_b0030","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/jn\/132.9.2486","article-title":"Metabolomics and Individual Metabolic Assessment: The Next Great Challenge for Nutrition","volume":"132","author":"German","year":"2002","journal-title":"J. Nutrit."},{"issue":"5","key":"10.1016\/j.ejpb.2021.05.025_b0035","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1074\/mcp.M112.021683","article-title":"Metabolomics Coupled with Proteomics Advancing Drug Discovery toward More Agile Development of Targeted Combination Therapies","volume":"12","author":"Wang","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.ejpb.2021.05.025_b0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2012.08.013","article-title":"Metabolomics and its potential in drug development","volume":"85","author":"Diren Beyoglu","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejpb.2021.05.025_b0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11306-017-1199-6","article-title":"Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics","volume":"13","author":"Lindahl","year":"2017","journal-title":"Metabolomics"},{"key":"10.1016\/j.ejpb.2021.05.025_b0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.aquatox.2013.10.024","article-title":"NMR-based metabolomics approach to study the toxicity of lambda-cyhalothrin to goldfish (Carassius auratus)","volume":"146","author":"Li","year":"2014","journal-title":"Aquat. Toxicol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.05.025_b0055","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00204-017-2079-6","article-title":"Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells","volume":"92","author":"Ramirez","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"7087","key":"10.1016\/j.ejpb.2021.05.025_b0060","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nature04648","article-title":"Pharmaco-metabonomic phenotyping and personalized drug treatment","volume":"440","author":"Andrew Clayton","year":"2006","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ejpb.2021.05.025_b0065","doi-asserted-by":"crossref","first-page":"13065","DOI":"10.1021\/acsnano.9b05793","article-title":"Predictive Metabolomic Signatures for Safety Assessment of Metal Oxide Nanoparticles","volume":"13","author":"Cui","year":"2019","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.ejpb.2021.05.025_b0070","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.3390\/nu12113457","article-title":"Effect of Zinc Supplementation on the Serum Metabolites Profile at the Early Stage of Breast Cancer in Rats","volume":"12","author":"Bobrowska-Korczak","year":"2020","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.ejpb.2021.05.025_b0075","doi-asserted-by":"crossref","first-page":"10419","DOI":"10.1021\/acsnano.9b04213","article-title":"Codoping Enhanced Radioluminescence of Nanoscintillators for X-ray-Activated Synergistic Cancer Therapy and Prognosis Using Metabolomics","volume":"13","author":"Ahmad","year":"2019","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.ejpb.2021.05.025_b0080","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1007\/s12161-017-0940-0","article-title":"Determination of Psoralens in Child Food (Soups and Baby Food) from Brazil by High-performance Liquid Chromatography (HPLC)","volume":"10","author":"Silva","year":"2017","journal-title":"Food Anal. Meth."},{"issue":"7","key":"10.1016\/j.ejpb.2021.05.025_b0085","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.phymed.2014.03.008","article-title":"Psoralen reverses docetaxel-induced multidrug resistance in A549\/D16 human lung cancer cells lines","volume":"21","author":"Hsieh","year":"2014","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.ejpb.2021.05.025_b0090","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3892\/mmr.2016.5098","article-title":"Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7\/ADR cells","volume":"13","author":"Jiang","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.ejpb.2021.05.025_b0095","first-page":"1055","article-title":"Fabrication of psoralen-loaded lipid-polymer hybrid nanoparticles and their reversal effect on drug resistance of cancer cells","volume":"40","author":"Yuan","year":"2018","journal-title":"Oncol. Rep."},{"issue":"28","key":"10.1016\/j.ejpb.2021.05.025_b0100","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1073\/pnas.0500756102","article-title":"An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers","volume":"102","author":"Joseph","year":"2005","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.ejpb.2021.05.025_b0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt0705-833","article-title":"Summary recommendations for standardization and reporting of metabolic analyses","volume":"23","author":"Lindon","year":"2005","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.ejpb.2021.05.025_b0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12094-011-0707-9","article-title":"Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics","volume":"13","author":"Casado-Vela","year":"2011","journal-title":"Clin. Transl. Oncol."},{"issue":"12","key":"10.1016\/j.ejpb.2021.05.025_b0115","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/mcp.M115.051938","article-title":"Integrated Metabolomics, Transcriptomics and Proteomics Identifies Metabolic Pathways Affected by Anaplasma phagocytophilum Infection in Tick Cells","volume":"14","author":"Villar","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"3","key":"10.1016\/j.ejpb.2021.05.025_b0120","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s11306-014-0725-z","article-title":"Metabolic transformation of breast cancer in a MCF-7 xenograft mouse model and inhibitory effect of volatile oil from Saussurea lappa Decne treatment","volume":"11","author":"Peng","year":"2015","journal-title":"Metabolomics"},{"issue":"7","key":"10.1016\/j.ejpb.2021.05.025_b0125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/10715762.2016.1164310","article-title":"Urinary markers of nucleic acid oxidation in Danish overweight\/obese children and youths","volume":"50","author":"Kloppenborg","year":"2016","journal-title":"Free Rad. Res."},{"key":"10.1016\/j.ejpb.2021.05.025_b0130","doi-asserted-by":"crossref","first-page":"e00090","DOI":"10.7554\/eLife.00090","article-title":"Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1","volume":"1","author":"Denard","year":"2012","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.ejpb.2021.05.025_b0135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1432-1033.1991.tb15840.x","article-title":"Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells","volume":"196","author":"Frezard","year":"1991","journal-title":"Eur. J. Biochem."},{"issue":"6","key":"10.1016\/j.ejpb.2021.05.025_b0140","first-page":"5162","article-title":"Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells","volume":"19","author":"Wen","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.ejpb.2021.05.025_b0145","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3892\/or.2014.3365","article-title":"Synergistic cytotoxic effect of genistein and doxorubicin on drug-resistant human breast cancer MCF-7\/Adr cells","volume":"32","author":"Xue","year":"2014","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.ejpb.2021.05.025_b0150","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/nnm-2017-0311","article-title":"Nanosized carriers based on amphiphilic poly-N-vinyl-2-pyrrolidone for intranuclear drug delivery","volume":"13","author":"Luss","year":"2018","journal-title":"Nanomedicine (Lond.)"},{"issue":"11","key":"10.1016\/j.ejpb.2021.05.025_b0155","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1194\/jlr.R100015-JLR200","article-title":"Gene expression regulation by retinoic acid","volume":"43","author":"James","year":"2002","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ejpb.2021.05.025_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-9-261","article-title":"Assessment of the effect of betaine on p16 and c-mycDNA methylation and mRNA expression in a chemical induced rat liver cancer model","volume":"9","author":"Du","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejpb.2021.05.025_b0165","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0151-9638(10)70002-8","article-title":"Hyaluronic acid and extracellular matrix: a primitive molecule?","volume":"137","author":"Nusgens","year":"2010","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"},{"issue":"5","key":"10.1016\/j.ejpb.2021.05.025_b0170","first-page":"448","article-title":"Clinical significance of hippurate-synthesizing capacity in surgical patients with liver disease: a metabolic tolerance test","volume":"108","author":"Aoyama","year":"1986","journal-title":"J. Lab. Clin. Med."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121001557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121001557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:48:49Z","timestamp":1760546929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121001557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":34,"alternative-id":["S0939641121001557"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.025","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening of metabolites in the treatment of liver cancer xenografts HepG2\/ADR by psoralen-loaded lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}